Pancreatic Cancer Research

ResearcherGifu University HospitalActive in the last 2 years

Hironao Ichikawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-4382-9401; OpenAlex author ID A5103994820. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 3 papers · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 7

  1. 11.5-Fr Large-Bore Plastic Stents Versus Fully Covered Self-Expandable Metallic Stents for the Management of Preoperative Endoscopic Biliary Obstruction in Pan… Co-author DOI 10.1007/s10620-026-10136-z↗
  2. Development of Pancreatic Cancer during the Follow-up of Autoimmune Pancreatitis: A Report of Two Cases. Co-author DOI 10.2169/internalmedicine.2086-23↗
  3. Impact of Controlling nutritional status (CONUT) in patients with unresectable advanced pancreatic cancer receiving multi-agent chemotherapy: A single center, … Co-author DOI 10.1016/j.pan.2022.01.010↗
  4. Covered self-expandable metallic stent versus plastic stent for preoperative endoscopic biliary drainage in patients with pancreatic cancer: a multi-center ret… Co-author DOI 10.1080/00365521.2021.2015802↗
  5. The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIRINOX therapy. Co-author DOI 10.1017/s0007114520003463↗
  6. Exosome Transfer Between Pancreatic-cancer Cells Is Associated With Metastasis in a Nude-mouse Model. Co-author DOI 10.21873/anticanres.15063↗
  7. Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Cen… Co-author DOI 10.3390/jcm10132848↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahito Shimizu · 7 shared papers, 2021–2026 · strength 1.26
  2. Shinya Uemura · 6 shared papers, 2021–2026 · strength 1.11
  3. Takuji Iwashita · 6 shared papers, 2021–2026 · strength 1.11
  4. Naoki Mita · 4 shared papers, 2021–2026 · strength 0.73
  5. Ryuichi Tezuka · 2 shared papers, 2022–2024 · strength 0.39
  6. Mitsuru Okuno · 2 shared papers, 2022–2026 · strength 0.39
  7. Akinori Maruta · 2 shared papers, 2022–2026 · strength 0.39
  8. Atsushi Suetsugu · 1 shared paper, 2021 · strength 0.15
  9. Tomoyuki Satake · 1 shared paper, 2021 · strength 0.15
  10. Robert M. Hoffman · 1 shared paper, 2021 · strength 0.15
  11. Kensaku Yoshida · 1 shared paper, 2022 · strength 0.13
  12. Ichiro Yasuda · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.